헤마테인을 함유하는 고지혈증 및 동맥경화증 예방 및 치료용 조성물
    11.
    发明公开
    헤마테인을 함유하는 고지혈증 및 동맥경화증 예방 및 치료용 조성물 失效
    用于保护或治疗含有高脂血症的药物组合物和含有HAEMATIN的阿片样物质

    公开(公告)号:KR1020000073945A

    公开(公告)日:2000-12-05

    申请号:KR1019990017558

    申请日:1999-05-17

    Abstract: PURPOSE: A haematin substance has characteristically an LDL(low density lipoprotein)-antioxidation, reduces the concentration of cholesterol in blood, and inhibits the activity of liver microsome ACAT(acyl-CoA: cholesterol acyl-transferase). Thereby, the pharmaceutical composition containing the haematin has an excellent effect for treating or protecting specific diseases such as hyperlipidemia or arteriosclerosis. CONSTITUTION: The haematin used is conventionally derivable from Heartwood of Caesalpinia sappan, or is available industrially. The pharmaceutical composition is used to treat or protect hyperlipidemia or arteriosclerosis by using usual haematin in drug, beverage or food.

    Abstract translation: 目的:血红素物质具有LDL(低密度脂蛋白) - 抗氧化作用,降低血液中胆固醇的浓度,并抑制肝微粒体ACAT(酰基辅酶A:胆固醇酰基转移酶)的活性。 因此,含有血红素的药物组合物对治疗或保护特异性疾病如高脂血症或动脉硬化具有优异的效果。 构成:所使用的血红素通常衍生自凯撒山茱萸的心材,或在工业上可用。 药物组合物用于通过在药物,饮料或食物中使用普通血红素来治疗或保护高脂血症或动脉硬化。

Patent Agency Ranking